z-logo
open-access-imgOpen Access
Medial prefrontal cortex in neurological diseases
Author(s) -
Pan Xu,
Ai Chen,
Yipeng Li,
Xuezhi Xing,
Hui Lü
Publication year - 2019
Publication title -
physiological genomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.078
H-Index - 112
eISSN - 1531-2267
pISSN - 1094-8341
DOI - 10.1152/physiolgenomics.00006.2019
Subject(s) - prefrontal cortex , neuroscience , schizophrenia (object oriented programming) , autism , anxiety , disease , depression (economics) , psychology , autism spectrum disorder , addiction , cognition , psychiatry , medicine , pathology , economics , macroeconomics
The medial prefrontal cortex (mPFC) is a crucial cortical region that integrates information from numerous cortical and subcortical areas and converges updated information to output structures. It plays essential roles in the cognitive process, regulation of emotion, motivation, and sociability. Dysfunction of the mPFC has been found in various neurological and psychiatric disorders, such as depression, anxiety disorders, schizophrenia, autism spectrum disorders, Alzheimer’s disease, Parkinson’s disease, and addiction. In the present review, we summarize the preclinical and clinical studies to illustrate the role of the mPFC in these neurological diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom